Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2025-12-24 @ 10:34 PM
NCT ID:
NCT04222335
Eligibility Criteria:
Inclusion Criteria:
* Patient with non operable and / or metastatic non-small cell lung cancer documented histologically.
* Pathological diagnosis of NSCLC carrying an EGFR activating mutation associated with sensitivity to the tyrosine kinase inhibitors (TKI) (exons 18, 19 and 21).
* Sufficient tissue sample quantity and quality for translational research
* Naïve TKI-treated EGFR patient who can receive first-line treatment with Osimertinib or second-line after chemotherapy
Exclusion Criteria:
* Any patient with an exon 20 EGFR mutation.
* Any disease or pathology that recommend not to perform blood samples collection
* Any psychological, family, geographical or social condition that could potentially, according to the investigator's judgment, prevent the collection of informed consent or interfere with compliance with the study protocol
* Patient with a resistance mutation of EGFR
* Patient under State Medical Assistance
* Patient deprived of liberty on administrative or judicial decision, or patient under guardianship, curatorship or safeguard of justice
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04222335
Study Brief:
Protocol Section:
NCT04222335